Effects of Klapp Method in Upper Cross Syndrome Patients

February 22, 2026 updated by: Riphah International University

Effects of Klapp Method on Posture, Craniovertebral Angle and Disability in Upper Cross Syndrome Patients

This study was conducted to determine the effects of Klapp Method on posture, craniovertebral angle and disability in upper cross syndrome patients.

Study Overview

Status

Not yet recruiting

Study Type

Interventional

Enrollment (Estimated)

40

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

    • Punjab Province
      • Rabwah, Punjab Province, Pakistan, 35460
        • Fazle Omar Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Both genders were included
  • Participants were between the ages of 18 to 40.
  • The craniovertebral angle was less than or equal to 50 degrees
  • The REEDCO Posture Assessment Scale of 59% or less.

Exclusion Criteria:

  • Patients that had a history of vascular syndrome, cervical spine infection, trauma, surgery, or cervical spine damage
  • Patients with inflammatory arthritis (such as rheumatoid arthritis or ankylosing spondylitis)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Klapp Method with Conventional Physical Therapy treatment

Klapp Method: 3 sessions/week for 6 weeks Four-point walk followed by two-point walk & back walk Breathing exercise from a kneeling position Simple bounce glide with simultaneous breathing Bunny hop

Breathing exercise from a quadrupedal position:

Greetings

Conventional Physical Therapy Treatment : 3 sessions/week for 6 weeks Hot pack 10 min Stretching exercises for Levator scapulae 3 sets for 30 sec hold each. Upper trapezius 3 sets for 30 sec hold each. Pectoralis stretches: 3 sets for 30 sec hold each.

Strengthening was given to :

Upper, Middle and Lower Trapezius: 10 repetitions 3 sets. Serratus anterior: 10 repetitions and 3 sets. Infraspinatus: 10 repetitions 3 sets. Deep neck flexors: 30 seconds hold 3 sets.

Active Comparator: Conventional Physical Therapy Treatment

Conventional Physical Therapy Treatment : 3 sessions/week for 6 weeks Hot pack 10 min Stretching exercises for Levator scapulae 3 sets for 30 sec hold each. Upper trapezius 3 sets for 30 sec hold each. Pectoralis stretches: 3 sets for 30 sec hold each.

Strengthening was given to :

Upper, Middle and Lower Trapezius: 10 repetitions 3 sets. Serratus anterior: 10 repetitions and 3 sets. Infraspinatus: 10 repetitions 3 sets. Deep neck flexors: 30 seconds hold 3 sets.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Craniovertebral Angle
Time Frame: From enrollment to the end of treatment at 6 weeks
Universal Goniometer is utilized to measure the craniovertebral angle. An angle between 50 to 53 degrees is considered normal
From enrollment to the end of treatment at 6 weeks
Reedco Posture Score
Time Frame: From enrollment to the end of treatment at 6 weeks
Reedco Posture score is used to assess posture. The RPS includes personal information about the person being evaluated, along with a scoring system for various body parts. Each body part is assigned a score between 0 and 10, with 10 indicating good posture 5 indicating fair posture, and 0 indicating poor posture. The total score is calculated by adding up the scores for all the body parts. A perfect score would be 100, indicating excellent posture.
From enrollment to the end of treatment at 6 weeks
Neck Disability Index
Time Frame: From enrollment to the end of treatment at 6 weeks
Neck Disability Index is 10-item questionnaire regarding functional activities of the neck. Each item has 6 categories with 0 being the least score and 5 being the highest score. The sum of the selected categories in each item are calculated and scored out of a total possible score of 50. The NDI score is assessed as a percentage if the patient skips an item.
From enrollment to the end of treatment at 6 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Ali Raza, Riphah International University

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

February 1, 2026

Primary Completion (Estimated)

November 18, 2026

Study Completion (Estimated)

November 18, 2026

Study Registration Dates

First Submitted

February 22, 2026

First Submitted That Met QC Criteria

February 22, 2026

First Posted (Actual)

February 27, 2026

Study Record Updates

Last Update Posted (Actual)

February 27, 2026

Last Update Submitted That Met QC Criteria

February 22, 2026

Last Verified

February 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • REC/RCR&AHS/24/01101

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Upper Cross Syndrome

Clinical Trials on Klapp Method

Subscribe